Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alumis Inc. - Common Stock (NQ:ALMS)

4.710 -0.170 (-3.48%)
Streaming Delayed Price Updated: 3:18 PM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,519,831
Open 4.950
Bid (Size) 4.680 (3)
Ask (Size) 4.710 (2)
Prev. Close 4.880
Today's Range 4.450 - 6.140
52wk Range 3.180 - 13.53
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers in Tuesday's session
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Performance

YTD
-42.7%
-42.7%
1 Month
+0.2%
+0.2%
3 Month
-6.9%
-6.9%
6 Month
-54.5%
-54.5%
1 Year
-64.6%
-64.6%

More News

Read More
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
From ACELYRIN, INC.
Via GlobeNewswire
Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
From ACELYRIN, INC.
Via GlobeNewswire
ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis
From ACELYRIN, INC.
Via GlobeNewswire
Charles Schwab To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Alumis and ACELYRIN Announce Amended Merger Agreement
From ACELYRIN, INC.
Via GlobeNewswire
Which stocks are moving on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Gapping stocks in Monday's session
Via Chartmill
Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday
Via Benzinga
3 Biopharmaceutical Stocks Bucking the Sell-Off
Via MarketBeat
Topics World Trade
Exposures Product Safety Tariff
Which stocks are moving on Tuesday?
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Top 3 Health Care Stocks That May Crash In Q2
Via Benzinga
Simulations Plus Posts Better-Than-Expected Results, Joins Savers Value Village, MarketAxess Holdings And Other Big Stocks Moving Higher On Friday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Progress Software Posts Upbeat Results, Joins Microvast, PVH And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session.
Via Chartmill
These stocks have an unusual volume in today's session
Via Chartmill
Top movers in Friday's session
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill

Frequently Asked Questions

Is Alumis Inc. - Common Stock publicly traded?
Yes, Alumis Inc. - Common Stock is publicly traded.
What exchange does Alumis Inc. - Common Stock trade on?
Alumis Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alumis Inc. - Common Stock?
The ticker symbol for Alumis Inc. - Common Stock is ALMS on the Nasdaq Stock Market
What is the current price of Alumis Inc. - Common Stock?
The current price of Alumis Inc. - Common Stock is 4.710
When was Alumis Inc. - Common Stock last traded?
The last trade of Alumis Inc. - Common Stock was at 05/21/25 03:18 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.